Client NewsOKYO Pharma Limited: Interview on Bloomberg – RedChip Money Report
New York and London- September 8, 2022 – OKYO Pharma Limited (NASDAQ: OKYO; LSE: OKYO;), a biotechnology company focused on the discovery and development of novel molecules to treat inflammatory dry eye diseases and ocular pain, today announces that an interview with its CEO, Dr Gary Jacob will air on The RedChip Money Report® on Bloomberg TV, this Saturday, September 10, at 7 p.m. Eastern Time (ET). Bloomberg TV is available in an estimated 73 million homes across the U.S.
In the exclusive RedChip Money Report interview, Dr. Gary Jacob discusses the Company’s NASDAQ listing, near term plans for the Phase 2 study for Dry Eye Disease, top-line data expectations, and much more.
Access this interview in its entirety at https://www.okyoinfo.com/interview_access
A replay will be available in the Investor Updates section of the Company’s website here:
OPEN AN ACCOUNT
If you are interested in opening an account with Optiva Securities, please fill in the details on the apply button.
Please ensure that the information you entered is accurate, and that your “Caps Lock” key is set correctly.